Working… Menu

Study of 2-hydroxyoleic Acid in Pediatric Patients With Malignant Glioma and Other Advanced Solid Tumors

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. Identifier: NCT04299191
Recruitment Status : Recruiting
First Posted : March 6, 2020
Last Update Posted : December 2, 2020
Hackensack Meridian Health
Dana-Farber Cancer Institute
Laminar Pharma Inc
Information provided by (Responsible Party):
Laminar Pharmaceuticals

No Study Results Posted on for this Study
Recruitment Status : Recruiting
Estimated Primary Completion Date : March 2022
Estimated Study Completion Date : March 2022